prioritising neonatal medicines research uk medicines for children research network scoping survey英国将新生儿的药物研究的儿童药物研究网络范围调查.pdfVIP

BMC Pediatrics BioMed Central Research article Open Access Prioritising neonatal medicines research: UK Medicines for Children Research Network scoping survey 1 2 1 3 Mark A Turner* , Sara Lewis , Daniel B Hawcutt and D Field Address: 1Division of Perinatal and Reproductive Medicine, University of Liverpool, Liverpool, UK, 2National Perinatal Epidemiology Unit, University of Oxford, Oxford, UK and 3Department of Health Sciences, University of Leicester, Leicester, UK Email: Mark A Turner* - mark.turner@liverpool.ac.uk; Sara Lewis - sara.lewis@npeu.ox.ac.uk; Daniel B Hawcutt - dhawcutt@liv.ac.uk; D Field - david.field@uhl-tr.nhs.uk * Corresponding author Published: 12 August 2009 Received: 10 May 2009 Accepted: 12 August 2009 BMC Pediatrics 2009, 9:50 doi:10.1186/1471-2431-9-50 This article is available from: /1471-2431/9/50 © 2009 Turner et al; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. Abstract Background: The dosing regimen and indications for many medicines in current use in neonatology are not well defined. There is a need to prioritise research in this area, but currently there is little information about which drugs are used in UK neonatal units a